series-c-plus
Stage
1
Investors
About
Aviceda Therapeutics develops cell therapy treatments focused on repairing brain injury and addressing neurological disorders.
Explore Aviceda Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.